Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient-Reference-Cited by-同舟云学术

Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient

Published:2022-09 Issue: Volume:30 Page:262-264
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Gaibani Paolo^ORCID,Amadesi Stefano,Lazzarotto Tiziana,Ambretti Simone

Funder

Ministero della Salute

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference7 articles.

1. Global spread of carbapenemase-producing Enterobacteriaceae;Nordmann;Emerg Infect Dis,2011

2. New β-lactam–β-lactamase inhibitor combinations;Yahav;Clin Microbiol Rev,2020

3. Resistance to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam in Gram-negative MDR bacilli: molecular mechanisms and susceptibility testing;Gaibani;Antiobitics,2022

4. Cross-resistance to cefiderocol and ceftazidime-avibactam in KPC β-lactamase mutants and the inoculum effect;Hobson;Clin Microbiol Infect,2021

5. A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocol

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies;Diagnostic Microbiology and Infectious Disease;2024-09

2. Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient;International Journal of Antimicrobial Agents;2024-06

3. Klebsiella pneumoniae carbapenemase variants: the new threat to global public health;Clinical Microbiology Reviews;2023-12-20

4. Characteristics of a ceftadine/avibatam resistance KPC-33-producing Klebsiella Pneumoniae strain with capsular serotype K19 belonging to ST15;Journal of Global Antimicrobial Resistance;2023-12

5. In vitro activity of cefiderocol in combination with new β-lactam/β-lactamase inhibitor combinations (βL-βLICs) against multidrug resistant KPC-producing Klebsiella pneumoniae;The Journal of Antibiotics;2023-08-30